The Fort Worth Press - Inspire Veterinary Partners Announces up to $10M in Financing at $1.00 per Share Through Cash and Transferred Securities

USD -
AED 3.672504
AFN 63.491204
ALL 81.288822
AMD 376.301041
ANG 1.789731
AOA 916.999751
ARS 1399.014201
AUD 1.411004
AWG 1.8
AZN 1.701035
BAM 1.648308
BBD 2.013148
BDT 122.236737
BGN 1.647646
BHD 0.37702
BIF 2948.551009
BMD 1
BND 1.263342
BOB 6.906578
BRL 5.228702
BSD 0.999486
BTN 90.53053
BWP 13.182358
BYN 2.864548
BYR 19600
BZD 2.010198
CAD 1.36158
CDF 2255.000162
CHF 0.76855
CLF 0.021845
CLP 862.58019
CNY 6.90865
CNH 6.884265
COP 3662.29826
CRC 484.785146
CUC 1
CUP 26.5
CVE 92.92908
CZK 20.446198
DJF 177.984172
DKK 6.29617
DOP 62.26691
DZD 129.636995
EGP 46.798197
ERN 15
ETB 155.660701
EUR 0.842798
FJD 2.19355
FKP 0.732487
GBP 0.733135
GEL 2.675023
GGP 0.732487
GHS 10.999115
GIP 0.732487
GMD 73.501836
GNF 8772.528644
GTQ 7.665922
GYD 209.102018
HKD 7.81484
HNL 26.408654
HRK 6.350898
HTG 131.053315
HUF 319.362998
IDR 16826
ILS 3.08903
IMP 0.732487
INR 90.70785
IQD 1309.386352
IRR 42125.000158
ISK 122.194926
JEP 0.732487
JMD 156.425805
JOD 0.709031
JPY 153.2095
KES 128.949834
KGS 87.45025
KHR 4020.092032
KMF 415.000135
KPW 900.035341
KRW 1440.675034
KWD 0.30662
KYD 0.832947
KZT 494.618672
LAK 21449.461024
LBP 89505.356044
LKR 309.057656
LRD 186.346972
LSL 16.041753
LTL 2.95274
LVL 0.60489
LYD 6.301675
MAD 9.139185
MDL 16.971623
MGA 4372.487379
MKD 51.950843
MMK 2099.386751
MNT 3566.581342
MOP 8.049153
MRU 39.835483
MUR 45.930117
MVR 15.40501
MWK 1733.150163
MXN 17.16123
MYR 3.902501
MZN 63.910238
NAD 16.041753
NGN 1354.150226
NIO 36.779052
NOK 9.49273
NPR 144.854004
NZD 1.656715
OMR 0.384513
PAB 0.999536
PEN 3.353336
PGK 4.290645
PHP 57.913016
PKR 279.547412
PLN 3.548899
PYG 6555.415086
QAR 3.642577
RON 4.289403
RSD 98.975902
RUB 76.645807
RWF 1459.237596
SAR 3.749501
SBD 8.045182
SCR 14.62101
SDG 601.508035
SEK 8.923101
SGD 1.261715
SHP 0.750259
SLE 24.450211
SLL 20969.49935
SOS 570.751914
SRD 37.753984
STD 20697.981008
STN 20.648358
SVC 8.745818
SYP 11059.574895
SZL 16.038634
THB 31.013503
TJS 9.429944
TMT 3.5
TND 2.881716
TOP 2.40776
TRY 43.733255
TTD 6.784604
TWD 31.353504
TZS 2606.829868
UAH 43.104989
UGX 3537.988285
UYU 38.531878
UZS 12284.028656
VES 392.73007
VND 25970
VUV 119.056861
WST 2.712216
XAF 552.845741
XAG 0.013152
XAU 0.0002
XCD 2.70255
XCG 1.801333
XDR 0.687563
XOF 552.845741
XPF 100.512423
YER 238.349837
ZAR 15.92555
ZMK 9001.199188
ZMW 18.166035
ZWL 321.999592
  • CMSD

    0.0647

    23.64

    +0.27%

  • BCC

    -1.5600

    86.5

    -1.8%

  • BCE

    -0.1200

    25.71

    -0.47%

  • RBGPF

    0.1000

    82.5

    +0.12%

  • GSK

    0.3900

    58.93

    +0.66%

  • JRI

    0.2135

    13.24

    +1.61%

  • AZN

    1.0300

    205.55

    +0.5%

  • CMSC

    0.0500

    23.75

    +0.21%

  • BTI

    -1.1100

    59.5

    -1.87%

  • NGG

    1.1800

    92.4

    +1.28%

  • RELX

    2.2500

    31.06

    +7.24%

  • RIO

    0.1600

    98.07

    +0.16%

  • VOD

    -0.0500

    15.57

    -0.32%

  • RYCEF

    0.2300

    17.1

    +1.35%

  • BP

    0.4700

    37.66

    +1.25%

Inspire Veterinary Partners Announces up to $10M in Financing at $1.00 per Share Through Cash and Transferred Securities
Inspire Veterinary Partners Announces up to $10M in Financing at $1.00 per Share Through Cash and Transferred Securities

Inspire Veterinary Partners Announces up to $10M in Financing at $1.00 per Share Through Cash and Transferred Securities

VIRGINIA BEACH, VA / ACCESS Newswire / August 4, 2025 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an owner and provider of pet health care services throughout the U.S., today announced that it has entered into a securities purchase agreement for the issuance and sale of securities under a new convertible preferred stock transaction. The consideration, consisting of a combination of cash and transferred securities, was valued at $1.00 per share.

Text size:

The gross proceeds to the Company from the offering are expected to be up to $10 million, including $6 million expected to be received through the investment of cash and securities at the first closing, and up to $4 million of cash that may be funded at one or more additional closings, at the election of the investors. The Company intends to use the net proceeds from the offering for general working capital and acquisitions of additional veterinary practices. The proceeds will also help to address current Nasdaq deficiencies around Shareholders Equity and extend cash on hand to maintain operations and extend runway.

"As communicated earlier in 2025, the team at IVP is executing on our growth strategy and this offering helps to facilitate our objectives," said President, Chairman and CEO, Kimball Carr, "With new acquisitions onboarded and record clinical hiring this year, I could not be prouder of our team for the continued progress being made across all departments within IVP."

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About Inspire Veterinary Partners, Inc.

Inspire Veterinary Partners is an owner and provider of pet health care services throughout the US. As the Company expands, it expects to acquire additional veterinary hospitals, including general practice, mixed animal facilities, and critical and emergency care. For more information, please visit: www.inspirevet.com.

Facebook | LinkedIn | X

Forward-Looking Statements

This press release contains forward-looking statements regarding the Company's current expectations. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Factors that could cause actual results to differ include, but are not limited to, statements by the Company relating to the completion of the offering, the satisfaction of customary closing conditions related to the offering, the intended use of proceeds from the offering, receipt of Stockholder Approval as well as risks and uncertainties related to the satisfaction of customary closing conditions related to anticipated acquisitions, or factors that result in changes to the Company's anticipated results of operations related to acquisitions. These and other risks and uncertainties are described more fully in the section captioned "Risk Factors" in the Company's public filings made with the Securities and Exchange Commission, including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

Investor Contact

CoreIR
Matt Blazei
516-386-0430
[email protected]

Press Contact

CORE IR
Matthew Cossel
[email protected]

General Inquires

Morgan Wood
[email protected]

SOURCE: INSPIRE VETERINARY PARTNERS, INC.



View the original press release on ACCESS Newswire

T.M.Dan--TFWP